Viosera Therapeutics
VerifiedViosera Therapeutics is a predict and block drug resistance in cancer and bacteria.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$2m (Public information from Mar 2019)
Sunnyvale California (HQ), San Francisco United States (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | $0.0 | round |
| investor | $0.0 Valuation: $0.0 | round | |
N/A | Seed | ||
| Total Funding | 000k | ||
Related Content
Recent News about Viosera Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.